BT bioAffinity Technologies, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the bioAffinity Technologies, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 14 January 2025 (Attribution). Among the most active insiders: GIRGENTI STEVEN. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 January 2025
All Executives62 Thresholds0 Prospectus0 Other0
Declarations 62 total
◆ President & CEO · Executives · 10 Jan 2025
37,037 shares 0Common Stock SEC:0001493152-25-002150:0
◆ Chief Operating Officer · Executives · 10 Jan 2025
21,604 shares 0Common Stock SEC:0001493152-25-002149:0
◆ VP and CFO · Executives · 10 Jan 2025
6,172 shares 0Common Stock SEC:0001493152-25-002146:0
◆ Secretary, EVP, Gen. Counsel · Executives · 10 Jan 2025
8,641 shares 0Common Stock SEC:0001493152-25-002147:0
◆ Executive Chairman · Executives · 10 Jan 2025
14,814 shares 0Common Stock SEC:0001493152-25-002148:0
◆ VP and CFO · Executives · 5 Nov 2024
100,000 shares 0Common Stock SEC:0001493152-24-043707:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026086:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026090:0
◆ Executive Chairman · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026092:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026088:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026091:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026085:0
◆ Director · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026089:0
◆ President & CEO · Executives · 1 Jul 2024
33,784 shares 0Common Stock SEC:0001493152-24-026087:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023995:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023997:0
◆ President & CEO · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023998:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023996:0
◆ Executive Chairman · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023994:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023992:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-024006:0
◆ Director · Executives · 12 Jun 2024
8,296 shares 0Common Stock SEC:0001493152-24-023993:0
◇ President & CEO · Executives · 8 Apr 2024
64,848 shares @ US$1.16 66.2% of flow Common Stock SEC:0001493152-24-015791:0
◇ Director · Executives · 3 Apr 2024
64,848 shares @ US$1.16 33.0% of flow Common Stock SEC:0001493152-24-015789:0
◇ Secretary, EVP, Gen. Counsel · Executives · 4 Apr 2024
64,848 shares @ US$1.16 100.0% of flow Common Stock SEC:0001493152-24-015790:0
25 of 62 declarations
Load more (37 remaining) 关于 bioAffinity Technologies, Inc. bioAffinity Technologies, Inc. 是一家专注于开发癌症诊断和治疗技术的公司。它旨在提供创新解决方案以改善患者预后。